Tag: Aprea Therapeutics

December 9, 2019

Aprea Therapeutics Presents Data from Phase 1b/2 Clinical Trial of APR-246

The company announced results at the 2019 ASh Annual Meeting for its French Phase 1b/2 clinical trial of APR-246.